Trials / Completed
CompletedNCT03831607
A Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on HD
A Phase 2, Open-label Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 67 (actual)
- Sponsor
- Kyowa Kirin Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the effect and safety of a switch from phosphate binders to KHK7791 to treat Hyperphosphatemia in patients on HD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KHK7791 | KHK7791 30 mg, 20 mg ,10 mg or 5 mg tablets |
Timeline
- Start date
- 2018-12-27
- Primary completion
- 2019-11-26
- Completion
- 2019-11-26
- First posted
- 2019-02-06
- Last updated
- 2024-03-07
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT03831607. Inclusion in this directory is not an endorsement.